云南高校图书馆联盟文献共享服务平台- PLERIXAFOR

PLERIXAFOR: 作品数：12被引量：48H指数：3; 导出分析报告; 相关作者：李梦朱传龙吕凤婷李毓雯张俊更多>>; 相关机构：中国科学院沈阳药科大学东南大学江苏省人民医院更多>>; 相关期刊：《药学进展》《Chinese Journal of Natural Medicines》《Blood Science》《国外药讯》更多>>; 相关基金：国家自然科学基金国家重点基础研究发展计划更多>>

Plerixafor-based mobilization and mononuclear cell counts in graft increased the risk of engraftment syndrome after autologous hematopoietic stem cell transplantation: 《Blood Science》2024年第3期48-54,共7页Le-Qing Cao Qi Wen Bo-Ning Liu Zhen-Yu Zhao Xiao-Hui Zhang Lan-Ping Xu Huan Chen Yu Wang Lu Yu Feng-Rong Wang Xiao-Jun Huang Xiao-Dong Mo; supported by the National Key Research and Development Program of China(2022YFC2502606);the National Natural Science Foundation of China(No.82170208,82200239);CAMS Innovation Fund for Medical Sciences(No.2022-I2M-C&T-B-121);Tongzhou district Distinguished Young Scholars(No.JCQN2023009);Peking University Health Science Center-University of Michigan College of Medicine Joint Institute for Translational and Clinical Research(BMU2022JI003);the Fundamental Research Funds for the Central Universities.; Engraftment syndrome(ES)is one of the most common complications in the early phase after autologous hematopoietic stem cell transplantation(ASCT),and we aimed to evaluate the incidence and risk factors for ES patients...; 关键词：Autologous stem cell transplantation Engraftment syndrome PLERIXAFOR Risk factors

Efficiency and safety analysis of Plerixafor combined with granulocyte colony-stimulating factor on autologous hematopoietic stem cell mobilization in lymphoma: 《China Medical Abstracts(Internal Medicine)》2023年第2期121-122,共2页纪濛濛; Objective To evaluate the advantages and safety of Plerixafor in combination with granulocyte colonystimulating factor(G-CSF)in autologous hematopoietic stem cell mobilization of lymphoma.Methods Lymphoma patients who...; 关键词：HEMATOPOIETIC LYMPHOMA AUTOLOGOUS

Hematopoietic stem cell mobilization strategies to support high-dose chemotherapy:A focus on relapsed/refractory germ cell tumors: 《World Journal of Clinical Oncology》2021年第9期746-766,共21页Eleni Porfyriou Sylvia Letsa Christos Kosmas; High-dose chemotherapy(HDCT)with autologous hematopoietic stem cell transplantation has been explored and has played an important role in the management of patients with high-risk germ cell tumors(GCTs)who failed to b...; 关键词：Hematopoietic stem cells Germ cell tumors Hematopoietic stem cell transplantation Granulocyte colony-stimulating factor PLERIXAFOR

Efficacy of Plerixafor for Peripheral Stem Cell Mobilisation in Autologous Transplantation: A Single Centre Study: 《Journal of Cancer Therapy》2020年第8期483-490,共8页Kiran Pura Krishnamurthy D. V. Ganesha Girish Badarkhe Diganta Hazarika Radheshyam Naik; Plerixafor is a stem cell mobilising agent, and when administered along with G-CSF has been shown to improve CD34+ stem cell collections in lymphoma and multiple myeloma patients compared to G-CSF alone. Patients who ...; 关键词：PLERIXAFOR Poor Mobilizers ASCT

The CXCL12(SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy被引量：38: 《Chinese Journal of Natural Medicines》2018年第11期801-810,共10页ZHOU Yu CAO Han-Bo LI Wen-Jun ZHAO Li; supported by the National Natural Science Foundation of China(Nos.81773774,81473231,and 81673461);Science Foundation for Distinguished Young Scholars of Jiangsu Province(No.BK20150028);the National Science and Technology Major Project(No.2017ZX09301014);the Project Program of State Key Laboratory of Natural Medicines,China Pharmaceutical University(No.SKLNMZZCX201823);Program for Changjiang Scholars and Innovative Research Team in University(No.IRT1193);the Open Project of State Key Laboratory Cultivation Base for TCM Quality and Efficacy,Nanjing University of Chinese Medicine(No.TCMQ&E201704); Chemokine 12(CXCL12), also known as stromal cell derived factor-1(SDF-1) and a member of the CXC chemokine subfamily, is ubiquitously expressed in many tissues and cell types. It interacts specifically with the ligand...; 关键词：CXCL12/CXCR4 Tumor Targeted therapy PLERIXAFOR

Chemokine-mimetic plerixafor derivative for tumorspecific delivery of nanomaterials: 《Nano Research》2018年第4期2159-2172,共14页Seungbeom Ko Gayong Shim Jinyoung Kim Yu-Kyoung Oh; Here, we report that chemokine-mimetic plerixafor derivatives could govern tumor-specific delivery and functional effects of nanomaterials. Reduced graphene oxide （rGO） nanosheets were used as a model functional nan...; 关键词：chemokine-mimetic plerixafor derivatives chemokine receptor NANOMATERIAL photothermal therapy

Update on acute myeloid leukemia stem cells:New discoveries and therapeutic opportunities被引量：3: 《World Journal of Stem Cells》2016年第10期316-331,共16页Maximilian Stahl Tae Kon Kim Amer M Zeidan; The existence of cancer stem cells has been wellestablished in acute myeloid leukemia. Initial proof of the existence of leukemia stem cells(LSCs) was accomplished by functional studies in xenograft models making use ...; 关键词：Leukemia stem cells Cancer stem cells Acute myeloid leukemia Stem cell niche XENOTRANSPLANTATION PLERIXAFOR NF-κ B C-X-C chemokine receptor type 4

High dose chemotherapy with stem cell support in the treatment of testicular cancer: 《World Journal of Stem Cells》2015年第11期1222-1232,共11页Lazar Popovic Gorana Matovina-Brko Milica Popovic Dragana Petrovic Ana Cvetanovic Jelena Vukojevic Darjana Jovanovic; Testicular germ cell cancer(TGCC) is rare form of malignant disease that occurs mostly in young man between age 15 and 40. The worldwide incidence of TGCC is 1.5 per 100000 man with the highest rates in North Europe. ...; 关键词：High DOSE chemotherapy Germ-cell cancer Stem cell TRANSPLANTATION PLERIXAFOR

Plerixafor(Mozobil)被引量：4: 《中国药物化学杂志》2009年第4期315-315,共1页高源赵临襄; 关键词：药品药物肿瘤 PLERIXAFOR

Plerixafor可以为干细胞移植“带来丰收”: 《国外药讯》2008年第5期23-23,共1页骆毅（摘）; 在美国血液病学会（ASH）第49届年度会议上报道的一项暂时的Ⅲ期临床研究结果显示，将plerixafor（Ⅰ）添加到粒细胞集落刺激因子（G—CSF）中的治疗可以使收集到的用于多发性骨髓瘤和非霍奇金淋巴瘤中移植的干细胞数量显著增加。在多...; 关键词：干细胞移植粒细胞集落刺激因子多发性骨髓瘤非霍奇金淋巴瘤干细胞收集 Ⅲ期临床研究干细胞数量血液病

PLERIXAFOR